National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011

Raymund Dantes1, Yi Mu, Ruth Belflower

  • 1Epidemic Intelligence Service, Scientific Education and Professional Development Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia2Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

JAMA Internal Medicine
|September 18, 2013
PubMed
Abstract

Insights

Invasive methicillin-resistant Staphylococcus aureus (MRSA) infections decreased by an estimated 30,800 cases nationally between 2005 and 2011. Prevention strategies outside of hospitals are crucial for further reducing MRSA burden.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Estimating the national burden of methicillin-resistant Staphylococcus aureus (MRSA) is vital for effective prevention strategies.
  • Updated national estimates of invasive MRSA infections are needed to track progress.

Purpose of the Study:

  • To provide updated national estimates and characteristics of health care- and community-associated invasive MRSA infections in 2011.
  • To analyze trends in invasive MRSA infections from 2005 to 2011.

Main Methods:

  • Active laboratory-based case finding in 9 US metropolitan areas from 2005-2011.
  • Classification of invasive MRSA infections into health care-associated community-onset (HACO), hospital-onset, and community-associated categories.
  • National estimates adjusted using US census and US Renal Data System data.

Main Results:

  • An estimated 80,461 invasive MRSA infections occurred nationally in 2011.
  • Incidence rates decreased by 27.7% for HACO and 54.2% for hospital-onset MRSA infections since 2005.
  • Community-associated MRSA infections decreased by only 5.0%, with a significant proportion linked to recent hospitalizations or long-term care facilities.

Conclusions:

  • An estimated 30,800 fewer invasive MRSA infections occurred in the US in 2011 compared to 2005.
  • Fewer infections occurred during hospitalization than in the community in 2011.
  • Targeting prevention strategies outside acute care settings is essential for further national reduction of invasive MRSA infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...